Catalyst Wire Dossier Catalyst Wire Dossier

RECORLEV

Levoketoconazole · Xeris Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RECORLEV, covering 2021-12-30 to 2023-08-16. Get the full timeline:

Most recent: FDA Approved: RECORLEV — Supplemental Application (Xeris Pharmaceuticals, Inc.)

See pricing